PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $5,515,652 | -13.0% | 2,495,770 | 0.0% | 0.80% | +17.3% |
Q1 2023 | $6,339,256 | +2853.7% | 2,495,770 | +2074.6% | 0.69% | +3935.3% |
Q4 2022 | $214,620 | -27.2% | 114,770 | 0.0% | 0.02% | -15.0% |
Q3 2022 | $295,000 | +32.9% | 114,770 | 0.0% | 0.02% | 0.0% |
Q2 2022 | $222,000 | -34.9% | 114,770 | 0.0% | 0.02% | -54.5% |
Q1 2022 | $341,000 | -33.9% | 114,770 | 0.0% | 0.04% | -39.7% |
Q4 2021 | $516,000 | -59.9% | 114,770 | -56.7% | 0.07% | -67.0% |
Q3 2021 | $1,287,000 | -28.7% | 264,770 | 0.0% | 0.22% | -43.9% |
Q2 2021 | $1,806,000 | +89.9% | 264,770 | +96.5% | 0.39% | +58.9% |
Q1 2021 | $951,000 | +8.4% | 134,770 | -3.7% | 0.25% | -13.9% |
Q4 2020 | $877,000 | +15.7% | 140,020 | 0.0% | 0.29% | +68.4% |
Q3 2020 | $758,000 | +3.7% | 140,020 | 0.0% | 0.17% | +3.6% |
Q2 2020 | $731,000 | +44.2% | 140,020 | -13.0% | 0.16% | +71.9% |
Q1 2020 | $507,000 | -87.0% | 160,870 | -83.4% | 0.10% | -67.6% |
Q4 2019 | $3,895,000 | -6.7% | 966,493 | 0.0% | 0.30% | +13.8% |
Q3 2019 | $4,176,000 | – | 966,493 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
CM Management, LLC | 200,000 | $972,000 | 0.72% |
GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |